No products in the cart.
#VisualAbstract: BRAF/MEK inhibitor therapy may be associated with risk of uveitis in patients with advanced melanoma
Click to read the study in the European Journal of Cancer.
Tag: sorafenib
Sorafenib maintenance therapy after allogenic stem cell transplantation reduces relapse rate in FLT3-ITD acute myeloid leukemia
1. Sorafenib maintenance therapy following allogenic stem cell transplantation in FLT3-ITD acute myeloid leukemia was associated with significantly lower rates ...
#VisualAbstract: Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer
1. Enzalutamide along with androgen-deprivation therapy was shown to significantly increase median overall survival among men with non-metastatic, castration-resistant prostate ...
Enzalutamide treatment increases median overall survival in non-metastatic prostate cancer
1. Enzalutamide along with androgen-deprivation therapy was shown to significantly increase median overall survival among men with non-metastatic, castration-resistant prostate ...
Atezolizumab-bevacizumab treatment increases survival in unresectable hepatocellular carcinoma
1. Combination treatment of atezolizumab and bevacizumab was shown to significantly increase overall survival and progression-free survival outcomes in patients ...
Sorafenib increases progression-free survival in patients with desmoid tumors
1. After 2 years of treatment with sorafenib, patients with desmoid tumors had significantly increased progression-free survival rates compared to ...
2 Minute Medicine Rewind June 30 – July 7, 2014
In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Effect of ...
No survival benefit with everolimus treatment for hepatocellular carcinoma [EVOLVE-1 Trial]
1. Compared to placebo, treatment with everolimus did not improve survival in patients with advanced hepatocellular carcinoma (HCC) who had ...
License Our Award-Winning Physician-Written Medical News and Visual Abstracts
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.